ADRENOCORTICAL CARCINOMA
Clinical trials for ADRENOCORTICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug shows promise in rare adrenal cancer trial
Disease control OngoingThis study tests the immunotherapy drug pembrolizumab in 39 adults with advanced adrenocortical carcinoma that cannot be removed by surgery. The main goal is to see if the drug can shrink tumors. Researchers will check if at least 8 out of 39 patients have their tumors shrink sig…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Heated chemo combo offers new hope for rare, deadly cancer
Disease control OngoingThis study tests a two-step treatment for adrenocortical carcinoma that has spread inside the abdomen. First, surgeons remove all visible tumors. Then, heated chemotherapy (cisplatin) is pumped directly into the belly to kill remaining cancer cells. The goal is to see if this app…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated May 17, 2026 00:50 UTC
-
New combo therapy shows promise for rare genitourinary cancers
Disease control OngoingThis study tests a combination of two immunotherapy drugs, nivolumab and ipilimumab, in about 100 adults with rare genitourinary cancers (like adrenal, penile, or bladder cancers). The goal is to see if the drugs can shrink tumors and control the disease. This is not a cure; pati…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for rare adrenal cancer
Disease control OngoingThis study tests a combination of two drugs, pembrolizumab and lenvatinib, in 30 adults with advanced adrenal cancer that has not responded to standard chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. Participants receive the drugs intrave…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Scientists dig into old records to crack rare Cancer's code
Knowledge-focused OngoingThis study reviews medical records from about 1,000 people with adrenocortical carcinoma (ACC), a rare and serious cancer. Researchers want to see how factors like age, sex, race, and how much cancer is in the body affect survival and how well treatments work. No new treatments a…
Matched conditions: ADRENOCORTICAL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Scientists hunt for vaccine targets in rare adrenal cancer
Knowledge-focused OngoingThis study is looking for the right targets (antigens) to create a vaccine that could help the immune system fight adrenocortical carcinoma, a rare and aggressive adrenal gland cancer. Researchers are studying blood and tissue samples from 150 people, including patients and healt…
Matched conditions: ADRENOCORTICAL CARCINOMA
Sponsor: University of Wuerzburg • Aim: Knowledge-focused
Last updated May 11, 2026 20:39 UTC